Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir and Asunaprevir +/- Beclabuvir in HIV/HCV Coinfection
NCT02124044Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Feb 2014
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of asunaprevir, daclatasvir, beclabuvir in hepatitis C (HCV), sponsored by National Institutes of Health. Started Feb 2014; status: completed.
02
Drugs
asunaprevirdaclatasvirbeclabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02124044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02124044.